Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations

Published:2015-06 Issue:6 Volume:169 Page:843-850
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Varga Cindy¹,Xie Wanling¹,Laubach Jacob¹,Ghobrial Irene M.¹,O'Donnell Elizabeth K.²,Weinstock Matthew¹,Paba-Prada Claudia¹,Warren Diane¹,Maglio Michelle E.¹,Schlossman Robert¹,Munshi Nikhil C.¹,Raje Noopur²,Weller Edie¹,Anderson Kenneth C.¹,Mitsiades Constantine S.²,Richardson Paul G.¹

Affiliation:

1. Dana Farber Cancer Institute; Harvard Medical School; Jerome Lipper Multiple Myeloma Center; Boston MA USA

2. Massachusetts General Hospital; Harvard Medical School; Boston MA USA

Funder

National Institutes of Health

Chambers Family Advanced Myeloma Research Fund

Cobb Family Myeloma Research Fund

de Gunzburg Myeloma Research Fund

Leukemia and Lymphoma Society

Multiple Myeloma Research Foundation

the Shawna Ashlee Corman Investigatorship in Multiple Myeloma Research

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13382/fullpdf

Reference24 articles.

1. Targeted therapy for multiple myeloma;Anderson;Seminars in Hematology,2001

2. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics;Bink;Haematologica,2008

3. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach;Blade;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2011

4. Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma;Cerny;European Journal of Haematology,2008

5. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system;Chang;British Journal of Haematology,2005

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review;Medicine;2024-04-05

2. Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors;Leukemia;2024-03-16

3. 1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study;Annals of Hematology;2024-01-11

4. Cytogenetic findings in testicular relapse of multiple myeloma: case report and literature review;Hematology, Transfusion and Cell Therapy;2024-01

5. Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease;Annals of Medicine;2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3